Clinical Trial Update: The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intraperitoneal docetaxel plus S-1 for malignant ascites associated with gastric cancer and peritoneal metastasis. The documen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)
• Taxotere (docetaxel) (docetaxel)

Snippet

Sponsor: Fudan University | Conditions: Stomach Neoplasms, Peritoneal Metastasis | Phase 2 | Status: UNKNOWN